• 1 Year Returns: 0.38%
• 3 Year Returns: 21.71%
• 5 Year Returns: 16.11%

• Pharmaceuticals | 72.38%
• Labs & Life Sciences Services | 21.68%
• Investment Banking & Brokerage | 3.35%
• Others | 1.66%
• Diversified Chemicals | 0.92%

• Sun Pharmaceutical Industries Ltd | 11.60%
• Apollo Hospitals Enterprise Ltd | 7.70%
• Cipla Ltd | 6.68%
• Fortis Healthcare Ltd | 4.56%
• Lupin Ltd | 4.55%

• Equity | 96.74%
• Cash & Equivalents | 3.26%

The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund is 5.76

Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund is 13.79

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund is -0.18

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund is -0.02

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.